Dr. Mark W. Schwartz serves as executive director at Targazyme, a biopharmaceutical company in San Diego, California, that develops point-of-care products designed to improve safety and clinical efficiency for cancer therapies. Also a member of the adjunct faculty at San Jose State University, Dr. Mark W. Schwartz belongs to the American Society of Clinical Oncology (ASCO).
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly